Yokosuka and iwakuni requires 22226/vitek 2 test card AST-GP67, 424703/vitek 2 AST-N809 test card, 420915/vitek 2 test card AST-ST02 - plus maintenance service
Ended Purchase Order Awarded Last action
- Contract number
- HT941024P0278
- Awardee
-
Biomerieux Japan LTD. UEI JZPDU6QCKX55
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,076
Award facts
- Opportunity
-
- Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables Solicitation · HT941024N0160 · Posted Sep 18, 2024
- Contract value 61% obligated
-
- $49,076.28 Current, with exercised options
- $80,243.01 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $30,191 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $18,885 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $80,243.01 firm fixed price purchase order to Biomerieux Japan LTD. on September 26, 2024, for VITEK 2 test card consumables and preventive maintenance services supporting U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The contract, which carries no set-aside designation, will deliver specialized antimicrobial susceptibility testing products including VITEK 2 AST-GP67, AST-N809, and AST-ST02 test cards, along with maintenance services for VITEK 2 Compact Analyzer systems. This sole-source procurement is scheduled for completion by September 30, 2027, and represents a direct award based on the unique compatibility requirements of government-owned laboratory equipment and the vendor's established capability to support Navy Medicine operations in the Pacific region.
Biomerieux Japan LTD., a subsidiary of France-based Biomerieux SA specializing in in vitro diagnostics and microbiological testing systems, serves as the prime contractor with no identified subcontractors. The contract supports critical laboratory diagnostic capabilities at forward-deployed U.S. military medical treatment facilities, ensuring reliable pathogen testing and susceptibility analysis for Naval medical personnel and eligible beneficiaries stationed in Japan. This award is part of a broader relationship between Biomerieux Japan LTD. and the Defense Health Agency, which has issued three related purchase orders totaling $238,738.38 through September 2027 for laboratory analyzer consumables and maintenance services.
Quick answers
Who was awarded contract HT941024P0278?
HT941024P0278 was awarded to Biomerieux Japan LTD. by Defense Health Agency (Department of Defense) on September 26, 2024.
How much is contract HT941024P0278 worth?
The government has obligated $49,076 on HT941024P0278. Its potential value, with all options, is $80,243.
Was contract HT941024P0278 competed?
The extent of competition for HT941024P0278 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award